ABBVIE, INC. for ABBVIE INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation Draft legislation relating to economic activity in Puerto Rico International tax issues, including OECD digital taxation work program
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| STEPHEN SCANGO | — |
Health Issues HCR
H.R. 1425, Patient Protection and Affordable Care Enhancement Act - provisions relating to pharmaceutical price controls H.R.6383, Uterine Fibroid Research and Education Act of 2020 340B drug discount program policy issues Drug cost and pricing policy issues Patient affordability issues Policy proposals relating to clinical trial diversity Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2021; Notice Requirement for Non-Federal Governmental Plans proposed rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| BINTA BEARD | — |
| STEPHEN SCANGO | — |
Medicare/Medicaid MMM
S. 2543, Prescription Drug Pricing Reduction Act of 2019 - Provisions related to Medicare Part D, Medicaid, and drug pricing S. 2911, Seniors Prescription Drug Relief Act of 2019 - Provisions related to Medicare Part D and Medicaid rebates Policy Proposals related to Medicare Part D and patient cost-sharing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| BINTA BEARD | — |
| STEPHEN SCANGO | — |
Trade (domestic/foreign) TRD
USMCA and related policy issues Policy proposals impacting biopharmaceutical supply chain
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| STEPHEN SCANGO | — |
Copyright/Patent/Trademark CPT
Patent litigation reform issues and issues related to post-grant proceedings at the PTO Value of intellectual property
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| BINTA BEARD | — |
| STEPHEN SCANGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.